Results 101 to 110 of about 50,045 (313)
Excellent hemostatic control during cardiac surgery in a patient with hemophilia B treated with albutrepenonacog alfa (
, 2023 Francisco José López‐Jaime +4 more
openalex +1 more source
A Comprehensive Approach: Addressing Psychological Needs in Gene Therapy for Haemophilia
Haemophilia, EarlyView.ABSTRACT Introduction Gene therapy (GT) represents a transformative development in the treatment of haemophilia, offering the potential for long‐lasting symptom control after a single administration. Although the scientific and medical aspects of this innovation have been widely studied, its psychological impact remains under‐addressed. Aims This paper
Aida Peyvandi +3 more
wiley +1 more source
Guidelines for management of hemophilia A and B [letter; comment] [PDF]
, 1995 Benjamin Djulbegović, G. Goldsmith
openalex +1 more source
Haemophilia, EarlyView.ABSTRACT Introduction Accurate monitoring of nonacog beta pegol (N9‐GP) is essential to ensure appropriate treatment and to avoid under‐ or overdosing, which may result in clinical complications. The product's extended half‐life, achieved through molecular modification, poses challenges for activity measurement, particularly when using a one‐stage ...
Marie Prudková +6 more
wiley +1 more source
Hemophilia B: Genetic Variants and Carrier Detection [PDF]
, 1977 Carol K. Kasper +2 more
openalex +1 more source
Haemophilia, EarlyView.ABSTRACT Introduction The expansion of haemophilia treatment to include non‐factor prophylaxis provides new options with various benefits, risks, administration modes, and device types, necessitating trade‐offs in decision‐making. Aim This study evaluated prophylactic treatment preferences of people with haemophilia and their caregivers, assessing ...
Hui Lu +12 more
wiley +1 more source
Evaluation of the Clinical Status of Patients with Inherited Bleeding Disorders in Diyala-Iraq
Diyala Journal of Medicine, 2019 Background: Inherited bleeding disorders are rare diseases that are both complicated and expensive to manage, they are classified into: coagulation factor disorders, vessel wall defect and platelet disorders.
Imad Ahmed Lateef
doaj +2 more sources
Clinical and Biomedical Research, 2023 Hemophilia is an inherited X-linked coagulopathy defined by a deficiency or abnormality in the clotting function of factor VIII (Hemophilia A) or factor IX (Hemophilia B).
Júlia Plentz Portich +7 more
doaj
TREATMENT OF HEMOPHILIA WITH HUMAN FACTORIX PRODUCED IN MAMIMARY TISSUE OF TRANSGENIC MAMMALS [PDF]
, 2008 Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention.
Drohan, William N. +4 more
core +1 more source